Your session is about to expire
← Back to Search
Mindfulness-based therapy for insomnia (MBTI) for Insomnia
Study Summary
This trial will study whether Mindfulness Based Therapy for Insomnia (MBTI) is an effective treatment for insomnia in black women, and whether it is feasible and acceptable to them.
- Insomnia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Who is qualified to partake in this trial?
"We are seeking 30 individuals with the sleep disorder, insomnia, ranging from 25 to 45 years old. Preference will be given to Black women who demonstrate fluency in English and meet DSM-5/ICSD3 criteria for insomnia (Insomnia Severity Index > 7) with at least 1 associated symptom causing daytime impairment."
How many participants are being accepted into this medical experiment?
"Affirmative. According to the details displayed on clinicaltrials.gov, this medical research project is actively searching for participants since it was posted on April 18th 2022 and updated recently on May 26th 2022. At present, 30 patients are needed from one trial location."
Are mature adults eligible to participate in this experiment?
"This medical investigation is searching for individuals between 25 and 45 years old."
Is this trial currently open to new participants?
"Yes, according to records published on clinicaltrials.gov this medical study is recruiting patients. On April 18th 2022 the trial was initially posted and has since been updated as recently as May 26th of this year. The research team are intending to enroll 30 participants at 1 location."
What is the ultimate goal of this research endeavor?
"This trial is designed to evaluate the efficacy of a new intervention by measuring changes in Five Facet Mindfulness Questionnaire (FFMQ) scores over time. Secondary outcome metrics entail evaluating alterations in Insomnia severity score, wake after sleep onset duration, and C-reactive protein [CRP] concentrations with criteria for meaningful change or remission specified as follows: 7+ point decrease on ISI scale; reduction of WASO minutes; 25 - 1600 pg/ml range for CRP test volume results."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger